Transforming Your Practice, Outcomes, and Productivity with Real-time Fluorescence Imaging of Wound Bacteria
Thomas E Serena, MD, FACS,MAPWCA, FACHM
CEO and Medical DirectorSerenaGroup IncCambridge, MA
Jeffrey D Lehrman, DPM, FASPS,MAPWCA, CPC, CPMA
Lehrman Consulting, LLCFort Collins, CO
Duration: 60 minutes
Talk Overview: In this webcast, Dr. Thomas Serena and Dr. Jeffrey Lehrman will focus on the clinical impact of and medical indications for use of fluorescence wound imaging and appropriate CPT coding for this procedure, explaining how to (i) use non-contact, real-time fluorescence imaging of bacterial presence and load, (ii) appropriately document the imaging procedure, findings, and medical necessity, and (iii) apply appropriate CPT codes for this procedure (with documentation tips).
Utility of Point-of-Care Fluorescence for Detection of Elevated Bacterial Burden in an Outpatient Wound Care Setting
Charles Andersen, MD, FACS, MAPWCA
Chief, Vascular/ Endovascular/ Limb Preservation, Surgery Service (Emeritus),
Chief Wound Care Service MAMC Medical Director Wound Care Clinic, Madigan
Army Medical Center, Tacoma, WA
Duration: 15 minutes
Talk Overview: Elevated bacterial burden hinders wound healing. The MolecuLight i:X handheld point-of-care fluorescence imaging system enhances detection of elevated bacterial loads in wounds, when used in combination with clinical assessment. This session will provide an overview of how this technology works, how it can be easily incorporated into your clinical workflow, and how increased information on bacterial burden informs clinical decision making.
Adopting Fluorescence Imaging for Detection of Elevated Bacterial Burden as a Standard of Care in our Long-Term Care Facilities
Martha Kelso, RN, LNC, HBOT
Chief Executive Officer, Wound Care Plus, LLC
Blue Springs, MO
Duration: 15 minutes
Talk Overview: Long-term care (LTC) facilities have a disproportionately high rate of wounds and related infections compared to the general population. Many of these wounds, if left undetected, require hospitalization and can lead to more serious complications such as sepsis. Early identification of bacterial burden in wounds is essential to preventing these detrimental outcomes. WoundCare Plus CEO Martha Kelso will describe how the information provided by fluorescence imaging, when used in combination with clinical assessment, improves detection of wounds with elevated bacterial burden. She will also describe how this additional information has transformed how her team of wound care consultants manages wounds in the LTC setting.
Clinical Perspective: My Experience Using & Billing for the MolecuLight Wound Imaging Procedure
Eric Lullove, DPM, CWSP, FAPWH(c)
Chief Medical Officer, West Boca Center for Wound Healing
Coconut Creek, FL
Duration: 15 minutes
Talk Overview: Adding MolecuLight i:X fluorescence imaging procedure to clinical assessment improves identification of wounds with elevated bacterial burden. In this session, Dr. Eric Lullove, Chief Medical Officer, West Boca Center for Wound Healing describes how fluorescence imaging informs his podiatric practice and share insights in billing for this procedure.
Legal and Medical Implications: Fluorescence Imaging for Detection of Elevated Bacterial Burden
Martha Kelso, RN, LNC, HBOT
Chief Executive Officer, Wound Care Plus, LLC
Blue Springs, MO
Duration: 15 minutes
Talk Overview: When new technology is introduced to the marketplace, the landscape can often change with evidence and clinician adoption of this technology. Being able to anticipate the ripple effect from a medical and legal implication can be invaluable when planning growth and strategy for medical organizations. Join Martha R Kelso as she discusses potential future implications and how her company, Wound Care Plus assimilated fluorescence imaging (MolecuLight i:X) into their wound care practice to reduce litigious events, while creating a standard of care in the long-term care setting.
Wound Cleanser Investigation: Which Cleansers Aren’t Getting the Job Done?
Alisha Oropallo, MD, FACS, FAPWCA
Chief Executive Officer, Wound Care Plus, LLC
Northwell Health
Lake Success, NY
Duration: 15 minutes
Talk Overview: Wound cleansing is an essential component of wound hygiene and overall care. Clinicians have many cleansers to select from but limited information on which cleanser is most efficacious for a given patient. In this session, we learn about the benefits of scrub vs. soak, specialized wound cleansers vs. saline, and compare the efficacy of 9 common cleansers through point-of-care fluorescence imaging for detection of elevated bacterial burden (MolecuLight i:X).
Proactive vs. Reactive Wound Care in the Hospital Outpatient Setting
Charles Andersen, MD, FACS, MAPWCA
Chief, Vascular/ Endovascular/ Limb Preservation, Surgery Service (Emeritus), Chief Wound Care Service MAMC Medical Director Wound Care Clinic, Madigan
Army Medical Center, Tacoma, WA
Duration: 15 minutes
Talk Overview:
This session describes how point-of-care fluorescence imaging (MolecuLight i:X) for detection of elevated bacterial burden is being successfully employed in a large hospital outpatient clinic to change to a more proactive wound care treatment algorithm. Learn how fluorescence imaging performed before, during and after traditional wound care strategies (e.g., cleaning, debridement) and advanced treatments (e.g., CTP placement) aids clinical decision making to address bacteria earlier, improve treatment efficacy and limit infection (including cellulitis) from progressing at this site.
This session describes how point-of-care fluorescence imaging (MolecuLight i:X) for detection of elevated bacterial burden is being successfully employed in a large hospital outpatient clinic to change to a more proactive wound care treatment algorithm. Learn how fluorescence imaging performed before, during and after traditional wound care strategies (e.g., cleaning, debridement) and advanced treatments (e.g., CTP placement) aids clinical decision making to address bacteria earlier, improve treatment efficacy and limit infection (including cellulitis) from progressing at this site.
Fluorescence Imaging is an Essential Tool for DFU Management: A 2-Year Analysis of Outcomes and Cost Savings in a Hospital Outpatient Clinic
Nadine Price, MSc, BSc (Hons) Podiatry
NELFT, NHS
London, UK
Duration: 15 minutes
Talk Overview:
This session describes results from a 2 year retrospective study comparing standard of care alone to standard of care with fluorescence imaging (MolecuLight i:X) of elevated bacterial burden. Learn how point-of-care information on wound bacterial burden provided by fluorescence imaging aided clinical decision making, leading to improved wound healing, reduced costs and reduced antimicrobial usage.
This session describes results from a 2 year retrospective study comparing standard of care alone to standard of care with fluorescence imaging (MolecuLight i:X) of elevated bacterial burden. Learn how point-of-care information on wound bacterial burden provided by fluorescence imaging aided clinical decision making, leading to improved wound healing, reduced costs and reduced antimicrobial usage.
